RHA Health Services is a licensed substance use treatment provider in Lenoir, NC, listed in the SAMHSA treatment directory. Clients can live on site in a residential program while they complete treatment. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidPrivate health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Children/AdolescentsYoung AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentCommission on Accreditation of Rehabilitation Facilities (CARF)Council on Accreditation (COA)National Committee for Quality Assurance (NCQA)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
301 East Meeting Street, Suite 101, Morganton, NC 28655
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare